145 related articles for article (PubMed ID: 7895784)
21. Residual erythroid progenitors in W/W mice respond to erythropoietin in the absence of steel factor signals.
Pharr PN; Hofbauer A; Worthington RE; Longmore GD
Int J Hematol; 2000 Aug; 72(2):178-85. PubMed ID: 11039666
[TBL] [Abstract][Full Text] [Related]
22. Induction of globin mRNA transcription by erythropoietin in differentiating erythroid precursor cells.
Nijhof W; Wierenga PK; Sahr K; Beru N; Goldwasser E
Exp Hematol; 1987 Aug; 15(7):779-84. PubMed ID: 3609181
[TBL] [Abstract][Full Text] [Related]
23. EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.
Juaristi JA; Aguirre MV; Todaro JS; Alvarez MA; Brandan NC
Toxicology; 2007 Mar; 231(2-3):188-99. PubMed ID: 17254689
[TBL] [Abstract][Full Text] [Related]
24. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects.
Wang W; Horner DN; Chen WL; Zandstra PW; Audet J
Biotechnol Bioeng; 2008 Apr; 99(5):1261-72. PubMed ID: 17969148
[TBL] [Abstract][Full Text] [Related]
25. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates.
Liang DC; Shih LY; Kuo MC; Chai IJ; Su TH; Chen SH; Liu HC; Shimosaka A
Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233
[TBL] [Abstract][Full Text] [Related]
26. Increased erythropoietin sensitivity of murine CFU-E and BFU-E in in vivo cultures.
Greenberg HM; Robinson SH
J Lab Clin Med; 1980 May; 95(5):706-13. PubMed ID: 6988531
[TBL] [Abstract][Full Text] [Related]
27. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.
Quinn J; Fisher PW; Capocasale RJ; Achuthanandam R; Kam M; Bugelski PJ; Hrebien L
Cytometry A; 2007 Aug; 71(8):612-24. PubMed ID: 17542025
[TBL] [Abstract][Full Text] [Related]
28. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
[TBL] [Abstract][Full Text] [Related]
29. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo.
Robinson Y; Matenov A; Tschöke SK; Weimann A; Oberholzer A; Ertel W; Hostmann A
Acta Anaesthesiol Scand; 2008 May; 52(5):605-13. PubMed ID: 18419713
[TBL] [Abstract][Full Text] [Related]
30. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11.
Hassan HT; Biermann B; Zander AR
Eur Cytokine Netw; 1996; 7(2):129-36. PubMed ID: 8688490
[TBL] [Abstract][Full Text] [Related]
31. Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo.
Thawani N; Tam M; Chang KH; Stevenson MM
Exp Hematol; 2006 Nov; 34(11):1451-61. PubMed ID: 17046564
[TBL] [Abstract][Full Text] [Related]
32. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE
Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
[TBL] [Abstract][Full Text] [Related]
33. The ontogeny of erythropoiesis in the mouse detected by the erythroid colony-forming technique. I. Hepatic and maternal erythropoiesis.
Rich IN; Kubanek B
J Embryol Exp Morphol; 1979 Apr; 50():57-74. PubMed ID: 458362
[TBL] [Abstract][Full Text] [Related]
34. Pure erythropoietic colony and burst formations in serum-free culture and their enhancement by insulin-like growth factor I.
Akahane K; Tojo A; Urabe A; Takaku F
Exp Hematol; 1987 Aug; 15(7):797-802. PubMed ID: 3609183
[TBL] [Abstract][Full Text] [Related]
35. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery.
Maltby S; Hughes MR; Zbytnuik L; Paulson RF; McNagny KM
Exp Hematol; 2009 Jan; 37(1):10-8. PubMed ID: 19004540
[TBL] [Abstract][Full Text] [Related]
36. The autonomous release of erythropoietic inhibition during long-term in vivo administration of actinomycin D.
Rich IN; Kubanek B
Exp Hematol; 1994 Apr; 22(4):341-7. PubMed ID: 8150032
[TBL] [Abstract][Full Text] [Related]
37. Special Education.
Kozutsumi H
Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
[TBL] [Abstract][Full Text] [Related]
38. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
Wood PA; Hrushesky WJ; Klevecz R
Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W
Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
[TBL] [Abstract][Full Text] [Related]
40. Activin A: a commitment factor in erythroid differentiation.
Shiozaki M; Kosaka M; Eto Y
Biochem Biophys Res Commun; 1998 Jan; 242(3):631-5. PubMed ID: 9464268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
